Navigation Links
Soliris(R) Improved Fatigue Independent of Changes in Anemia in Patients with PNH by Controlling Hemolysis
Date:6/14/2008

ude disabling fatigue," said Dr. Hill. "The data presented at EHA help us to understand that fatigue in PNH is tied much more closely to hemolysis than to anemia, and emphasize the importance of eculizumab therapy in providing a better quality of life to patients with PNH, independent of any changes in anemia they experience."

Soliris, developed by Alexion Pharmaceuticals, Inc. (Nasdaq: ALXN) was approved in the U.S. and European Union in 2007; Soliris is indicated in the U.S. for the treatment of patients with PNH to reduce hemolysis and is indicated in the EU for the treatment of patients with PNH. PNH is a rare, debilitating and life-threatening blood disease in which hemolysis, caused by the patient's own immune system, can cause thromboses (blood clots), disabling fatigue, anemia, impaired quality of life, shortness of breath, recurrent pain, kidney disease and intermittent episodes of dark-colored urine (hemoglobinuria). (2-4)

Soliris, Hemolysis and Fatigue in PNH

Fatigue levels in patients with PNH are often severe and similar to those experienced by anemic cancer patients. Soliris has been shown to reduce substantially the frequently disabling fatigue associated with PNH. The data presented today provide additional insight into the mechanism through which Soliris positively impacts PNH-related fatigue. While treatments designed to improve anemia can improve fatigue in both PNH and cancer, these data demonstrate that fatigue in PNH is also related directly to chronic hemolysis and can be improved independent of correction of anemia. Soliris has also been associated with other significant benefits in patients with PNH, including reduction in hemolysis and reduction in thrombotic events during treatment phase compared t
'/>"/>

SOURCE Alexion Pharmaceuticals, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9

Related medicine technology :

1. Alexion Completes Enrollment in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
2. Alexion Commences Dosing in AEGIS Registration Study of Soliris(R) (eculizumab) in Patients with PNH in Japan
3. PNH Patients With Lower Levels of Hemolysis, Mild Anemia and Minimal Transfusion Support Have Significant Disease Burden; Soliris(R) Therapy Provided Clinical Improvements in PNH Patients Regardless of Disease Severity
4. Long-Term Soliris(R) Therapy Improved or Stabilized Kidney Function in Patients With PNH
5. Soliris(R) Demonstrates Reductions in Hemolysis and Improvements in Fatigue, Overall Quality of Life and Anemia in a Broad Population of PNH Patients
6. Data From Two Phase 3 Studies Show Anti-TNF Golimumab Significantly Improved Signs and Symptoms of Rheumatoid Arthritis
7. Ambien CR(R) (zolpidem tartrate extended-release) CIV Tablets Improved Insomnia and Daily Functioning in Patients with Co-Morbid Major Depressive Disorder
8. Monotherapy BYETTA(R) (exenatide) Injection Study Results Presented at ADA 2008 Showed Adults with Type 2 Diabetes Experienced Improved Glycemic Control and Weight Loss
9. Final Results of the CellCept(R) Spare the Nephron (STN) Study Show Maintenance Therapy is Associated with Improved Renal Function
10. Data Published at ASCO Find Correlation Between ChemoFx(R) Assay and Significantly Improved Overall Survival in Patients With Ovarian Cancer
11. New Study Suggests Tapentadol IR for Acute Pain Is Associated With Improved Gastrointestinal Tolerability Compared to Oxycodone IR
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/2/2015)... YORK , Sept. 2, 2015   About ... the most common laboratory technologies that is used for ... antibodies in solution. ELISA test uses various types of ... phosphatases and the result is detected by photometry or ... the treatment of various infectious diseases such as HIV, ...
(Date:9/2/2015)... Calif. , Sept. 2, 2015 STAAR Surgical ... marketer of implantable lenses and delivery systems for the eye, ... William P. Wall to the Company,s Board. ... Capital, a Boston -based investment firm, for ... of the Board of Directors, and chair of the Corporate ...
(Date:9/2/2015)... -- Research and Markets ( http://www.researchandmarkets.com/research/275q7t/inhaled_drug ) has announced ... UK - November 19-20, 2015)" conference to their ... cover industry case studies, regulatory updates, latest therapies and ... Steven Nichols , OINP Specialist Consultant and ... Companies participating include: - Aptar Pharma ...
Breaking Medicine Technology:Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 2Global Enzyme-Linked Immunosorbent Assay (Elisa) Testing Market 2015-2019 3William P. Wall Appointed to STAAR Surgical Board of Directors 2
(Date:9/3/2015)... ... September 03, 2015 , ... Representatives with ... at the highly anticipated Mississippi Gulf Babypalooza on September 19, 2015. , “We ... from Gulfport, Biloxi, and beyond. We will be discussing setting up college funds, ...
(Date:9/3/2015)... ... September 03, 2015 , ... At Renew Man™, we have seen an ... health care model, where the primary care physician dictates and the patient obeys. Instead, ... educated about their health issues and empowered to choose their own treatment options. , ...
(Date:9/3/2015)... ... September 03, 2015 , ... About 220,800 new cases of prostate cancer are reported each year, ... diagnosed with prostate cancer during their lifetime. While only one man in 10,000 will typically ... by age 65, according to the American Cancer Society. , Prostate ...
(Date:9/3/2015)... ... September 03, 2015 , ... James Earl Jones will ... wellness. In this episode, James Earl Jones will introduce a segment that discusses why ... workplace and how workplace wellness can be fostered in any working environment. , Employers ...
(Date:9/3/2015)... FLORIDA (PRWEB) , ... September 03, 2015 , ... ... of the highest-regarded health professionals out there. His perspective on internal medicine keeps patients ... stay happy and healthy is important regardless of the season, but even more so ...
Breaking Medicine News(10 mins):Health News:State Farm Agent EJ Roberts to Help Expecting Mothers at the Mississippi Gulf Babypalooza 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 2Health News:Men Dissatisfied with the Primary Care Physician’s Approach to Andropause Are Turning to Renew Man™ 3Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 2Health News:Noted Santa Rosa Urologist Dr. Michael Lazar Provides Insights on Prostate Cancer Treatments in Recognition of Prostate Cancer Awareness Month 3Health News:James Earl Jones Hosts a New "Voices In America" Piece on Making the Workplace Healthier 2Health News:Doctor Kayode Sotonwa Highlights Expert Tips for Staying in Shape This Fall 2
... Eli Lilly and Company (NYSE: LLY ) today declared a ... outstanding common stock. This is the same dividend as was paid ... rate for 2009 of $1.96 per share. , , The ... close of business on August 15, 2009. , , About Lilly ...
... blames physician misdiagnosis as the likely cause of apparent uptick ... A newly released study in the June 2009 British Journal ... the eastern United Kingdom has concluded that the much-hyped melanoma ... The study attributed the increase in melanoma diagnoses to heightened ...
... Now there,s a new reason for the,weight-conscious to drink fat ... the July issue of the American Journal of Clinical,Nutrition. Researchers ... helped increase satiety, or a feeling of fullness, and lead ... a fruit drink. The,milk drinkers ate about 50 fewer calories ...
... Personalized Medicine Meeting Elicits Varying Perspectives , , WASHINGTON, ... to regulate genetic testing is problematic, according to a recent ... of the attendees at a colloquium on personalized medicine, sponsored ... American Association for the Advancement of Science (AAAS) responded "yes" ...
... to attend field hearing exploring use of Recovery Act funds ... Senator Benjamin L. Cardin (D-MD ), chaired a field hearing ... Entrepreneurship in Rockville, MD, entitled " Missed Opportunities: The ... local and national experts in biotechnology testified about the important ...
... Center,s two camps, Camp Courage in Maple Lake and Courage North ... people with disabilities. , , A recent Muscular Dystrophy camp ... MDA staff) who tested positive for H1N1 flu (also known as ... officials were contacted by the MDA locally three days after the ...
Cached Medicine News:Health News:New Study Says Purported Melanoma Epidemic is Vastly Overstated 2Health News:Drinking Milk in the Morning May Help Stave off Lunchtime Hunger 2Health News:FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say 2Health News:FDA's Current Ability to Regulate Genetic Testing is Problematic, FDLI-AAAS Colloquium Attendees Say 3Health News:Cardin Calls on NIH to Utilize Small Businesses for Extramural Research Projects 2Health News:Courage Camps Maintain Summer Camp Schedule for Children and Adults With Disabilities 2
Rapid Test Kit...
... Advanced Vision Information System) is an open ... on a platform designed to communicate and ... network can be expanded in various ways, ... Nidek products but also to fundus cameras ...
... laser photocoagulators includes the OcuLight SL and ... as a single laser source for multiple ... maintenance or special electrical/cooling, and allow easy ... SLx is now available with Tri-Mode capability ...
The simplest, most accurate Ortho-K lens fitting system ever!...
Medicine Products: